Project Number 5U01AG031106-03 Agency/Funding Organization NIA Funding Year 2010 View Full Project Details for NOVEL HSP90 INHIBITORS TO REDUCE MISFOLDED PROTEINS IN ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) i. Proteostasis/Proteinopathies Researcher and Organization Principal Investigator MICHAELIS, MARY L. Principal Investigator First Name MARY L. Principal Investigator Last Name MICHAELIS Awardee Organization UNIVERSITY OF KANSAS LAWRENCE Awardee State Kansas Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-05-148: Alzheimer's Disease Drug Development Program FY Overall Cost $558,423 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL
